vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and InvenTrust Properties Corp. (IVT). Click either name above to swap in a different company.
InvenTrust Properties Corp. is the larger business by last-quarter revenue ($77.4M vs $44.9M, roughly 1.7× AbCellera Biologics Inc.). InvenTrust Properties Corp. runs the higher net margin — 3.4% vs -19.9%, a 23.4% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 8.6%). InvenTrust Properties Corp. produced more free cash flow last quarter ($110.9M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 7.6%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.
ABCL vs IVT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $77.4M |
| Net Profit | $-8.9M | $2.7M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | -11.0% |
| Net Margin | -19.9% | 3.4% |
| Revenue YoY | 788.4% | 8.6% |
| Net Profit YoY | 73.9% | -72.8% |
| EPS (diluted) | $-0.03 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $77.4M | ||
| Q3 25 | $9.0M | $74.5M | ||
| Q2 25 | $17.1M | $73.6M | ||
| Q1 25 | $4.2M | $73.8M | ||
| Q4 24 | $5.0M | $71.2M | ||
| Q3 24 | $6.5M | $68.5M | ||
| Q2 24 | $7.3M | $67.4M | ||
| Q1 24 | $10.0M | $66.8M |
| Q4 25 | $-8.9M | $2.7M | ||
| Q3 25 | $-57.1M | $6.0M | ||
| Q2 25 | $-34.7M | $95.9M | ||
| Q1 25 | $-45.6M | $6.8M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | $-51.1M | $-539.0K | ||
| Q2 24 | $-36.9M | $1.5M | ||
| Q1 24 | $-40.6M | $2.9M |
| Q4 25 | -63.7% | -11.0% | ||
| Q3 25 | -851.8% | -9.8% | ||
| Q2 25 | -290.2% | — | ||
| Q1 25 | -1479.6% | -10.5% | ||
| Q4 24 | — | -3.6% | ||
| Q3 24 | -1439.4% | -18.7% | ||
| Q2 24 | -1276.2% | -13.6% | ||
| Q1 24 | -551.5% | -13.1% |
| Q4 25 | -19.9% | 3.4% | ||
| Q3 25 | -637.8% | 8.1% | ||
| Q2 25 | -203.3% | 130.4% | ||
| Q1 25 | -1077.2% | 9.2% | ||
| Q4 24 | — | 13.8% | ||
| Q3 24 | -785.4% | -0.8% | ||
| Q2 24 | -504.3% | 2.2% | ||
| Q1 24 | -408.0% | 4.3% |
| Q4 25 | $-0.03 | $0.02 | ||
| Q3 25 | $-0.19 | $0.08 | ||
| Q2 25 | $-0.12 | $1.23 | ||
| Q1 25 | $-0.15 | $0.09 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | $-0.17 | $-0.01 | ||
| Q2 24 | $-0.13 | $0.02 | ||
| Q1 24 | $-0.14 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | $825.9M |
| Stockholders' EquityBook value | $966.9M | $1.8B |
| Total Assets | $1.4B | $2.8B |
| Debt / EquityLower = less leverage | — | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | — | $825.9M | ||
| Q3 25 | — | $764.6M | ||
| Q2 25 | — | $746.3M | ||
| Q1 25 | — | $740.7M | ||
| Q4 24 | — | $740.4M | ||
| Q3 24 | — | $740.1M | ||
| Q2 24 | — | $812.2M | ||
| Q1 24 | — | $827.5M |
| Q4 25 | $966.9M | $1.8B | ||
| Q3 25 | $964.0M | $1.8B | ||
| Q2 25 | $1.0B | $1.8B | ||
| Q1 25 | $1.0B | $1.7B | ||
| Q4 24 | $1.1B | $1.8B | ||
| Q3 24 | $1.1B | $1.8B | ||
| Q2 24 | $1.1B | $1.5B | ||
| Q1 24 | $1.1B | $1.5B |
| Q4 25 | $1.4B | $2.8B | ||
| Q3 25 | $1.4B | $2.7B | ||
| Q2 25 | $1.4B | $2.7B | ||
| Q1 25 | $1.3B | $2.6B | ||
| Q4 24 | $1.4B | $2.6B | ||
| Q3 24 | $1.4B | $2.6B | ||
| Q2 24 | $1.4B | $2.5B | ||
| Q1 24 | $1.5B | $2.5B |
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | — | 0.42× | ||
| Q3 24 | — | 0.42× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $155.4M |
| Free Cash FlowOCF − Capex | $-44.6M | $110.9M |
| FCF MarginFCF / Revenue | -99.4% | 143.3% |
| Capex IntensityCapex / Revenue | 21.9% | 57.5% |
| Cash ConversionOCF / Net Profit | — | 58.41× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $193.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $155.4M | ||
| Q3 25 | $-52.6M | $43.8M | ||
| Q2 25 | $-32.4M | $48.7M | ||
| Q1 25 | $-11.6M | $20.2M | ||
| Q4 24 | $-108.6M | $136.9M | ||
| Q3 24 | $-28.9M | $38.4M | ||
| Q2 24 | $-30.0M | $46.7M | ||
| Q1 24 | $-41.7M | $14.8M |
| Q4 25 | $-44.6M | $110.9M | ||
| Q3 25 | $-61.5M | $31.4M | ||
| Q2 25 | $-45.8M | $38.0M | ||
| Q1 25 | $-22.2M | $12.8M | ||
| Q4 24 | $-187.0M | $100.8M | ||
| Q3 24 | $-47.4M | $29.3M | ||
| Q2 24 | $-50.1M | $37.2M | ||
| Q1 24 | $-65.8M | $7.7M |
| Q4 25 | -99.4% | 143.3% | ||
| Q3 25 | -687.0% | 42.2% | ||
| Q2 25 | -267.9% | 51.6% | ||
| Q1 25 | -524.0% | 17.4% | ||
| Q4 24 | -3702.8% | 141.5% | ||
| Q3 24 | -728.4% | 42.8% | ||
| Q2 24 | -683.8% | 55.2% | ||
| Q1 24 | -661.5% | 11.5% |
| Q4 25 | 21.9% | 57.5% | ||
| Q3 25 | 99.7% | 16.7% | ||
| Q2 25 | 78.2% | 14.6% | ||
| Q1 25 | 251.1% | 10.0% | ||
| Q4 24 | 1552.7% | 50.7% | ||
| Q3 24 | 284.6% | 13.3% | ||
| Q2 24 | 274.6% | 14.0% | ||
| Q1 24 | 242.5% | 10.6% |
| Q4 25 | — | 58.41× | ||
| Q3 25 | — | 7.27× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 2.97× | ||
| Q4 24 | — | 13.97× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 31.15× | ||
| Q1 24 | — | 5.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
